Kuhnil Pharmaceutical received sales approval of 'Circadin' which is the world's only insomnia treatment

On June 27, Kuhnil Pharmaceutical announced that they received sales approval of 'Circadin' which is the world's only insomnia treatment with the ingredient of melatonin to the Ministry of Food and Drug Safety.

'Circadin' is the first sustained release melatonin agent which is similar to the release of endogenous melatonin. It preserved the sleep structure adjusting sleep and circadian rhythms...